Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FDJC1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,365
Award facts
- Contract value 100% obligated
- $12,364.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, and represents a routine pharmaceutical supply transaction without set-aside designation. The award was issued under DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for Department of Defense pharmaceutical supply needs.
DMS Pharmaceutical Group, registered in the System for Award Management since 2001, has established itself as a critical supplier within the federal pharmaceutical supply chain, demonstrating substantial contracting activity through numerous delivery orders from the Defense Logistics Agency's Medical Supply Chain division. The company's comprehensive product portfolio encompasses branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals serving military healthcare facilities worldwide. As a single-award IDC contractor under PPV-G GEN V with a ceiling value of $499,999,999 and completion date of December 31, 2036, the company is positioned to support the Department of Defense's recurring medical supply requirements across its global healthcare operations with no identified subcontractor relationships on this award.
Quick answers
Who was awarded contract SPE2DR26FDJC1?
SPE2DR26FDJC1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FDJC1 worth?
The government has obligated $12,365 on SPE2DR26FDJC1.
Is contract SPE2DR26FDJC1 an order under another contract?
Yes. SPE2DR26FDJC1 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJC1 competed?
The extent of competition for SPE2DR26FDJC1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award